Copyright

Drug-eluting stents, Dual antiplatelet therapy, High bleeding risk, High thrombotic risk, Zotarolimus-eluting stent
dx.doi.org/10.1097/HCO.0000000000000185, hdl.handle.net/1765/88886
Current Opinion in Cardiology
no subscription
Erasmus MC: University Medical Center Rotterdam

Ariotti, S, Costa, F, & Valgimigli, M. (2015). Coronary stent selection and optimal course of dual antiplatelet therapy in patients at high bleeding or thrombotic risk: Navigating between limited evidence and clinical concerns. Current Opinion in Cardiology (Vol. 30, pp. 325–332). doi:10.1097/HCO.0000000000000185